Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6231-6240

  Munitic, Ivana ^a,b   Giardino Torchia, Maria Letizia ^a   Meena, Netra Pal ^a   Zhu, Guozhi ^a   Li, Caiyi C ^a   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of Rijeka   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CARRIER PROTEINS AND BINDING PROTEINS; CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; OPTINEURIN; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BACKCROSSING; BINDING SITE; BONE MARROW; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURVIVAL; T LYMPHOCYTE; UBIQUITINATION;

EID: 84890424048     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301696     Document Type: Article

References (69)

1. Ghosh, S., and M. S. Hayden. 2012. Celebrating 25 years of NF-κB research. Immunol. Rev. 246: 5-13.
2. Lebrun-Julien, F., L. Duplan, V. Pernet, I. Osswald, P. Sapieha, P. Bourgeois, K. Dickson, D. Bowie, P. A. Barker, and A. Di Polo. 2009. Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. J. Neurosci. 29: 5536-5545.
3. Sen, R., and S. T. Smale. 2010. Selectivity of the NF-kappaB response. Cold Spring Harb. Perspect. Biol. 2: a000257.
4. Gerondakis, S., and U. Siebenlist. 2010. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2: a000182.
5. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
6. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650.
7. Israël, A. 2010. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2: a000158.
8. Wu, C. J., D. B. Conze, T. Li, S. M. Srinivasula, and J. D. Ashwell. 2006. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 8: 398-406.
9. Ea, C. K., L. Deng, Z. P. Xia, G. Pineda, and Z. J. Chen. 2006. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22: 245-257.
10. Wu, C. J., and J. D. Ashwell. 2008. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. USA 105: 3023-3028.
11. Conze, D. B., C. J.Wu, J. A. Thomas, A. Landstrom, and J. D. Ashwell. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation. Mol. Cell. Biol. 28: 3538-3547.
12. Zhao, T., L. Yang, Q. Sun, M. Arguello, D. W. Ballard, J. Hiscott, and R. Lin. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8: 592-600.
13. Zeng, W., M. Xu, S. Liu, L. Sun, and Z. J. Chen. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36: 315-325.
14. Wang, L., S. Li, and M. E. Dorf. 2012. NEMO binds ubiquitinated TANK-binding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses. PLoS ONE 7: e43756.
15. Wagner, S., I. Carpentier, V. Rogov, M. Kreike, F. Ikeda, F. Löhr, C. J. Wu, J. D. Ashwell, V. Dötsch, I. Dikic, and R. Beyaert. 2008. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745.
16. Laplantine, E., E. Fontan, J. Chiaravalli, T. Lopez, G. Lakisic, M. Veron, F. Agou, and A. Israel. 2009. NEMO specifically recognizes K63-linked polyubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 28: 2885-95.
17. Schwamborn, K., R. Weil, G. Courtois, S. T. Whiteside, and A. Israël. 2000. Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J. Biol. Chem. 275: 22780-22789.
18. Zhu, G., C. J. Wu, Y. Zhao, and J. D. Ashwell. 2007. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr. Biol. 17: 1438-1443.
19. Nagabhushana, A., M. Bansal, and G. Swarup. 2011. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation. PLoS ONE 6: e17477.
20. Morton, S., L. Hesson, M. Peggie, and P. Cohen. 2008. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 582: 997-1002.
21. Gleason, C. E., A. Ordureau, R. Gourlay, J. S. Arthur, and P. Cohen. 2011. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J. Biol. Chem. 286: 35663-35674.
22. Mankouri, J., R. Fragkoudis, K. H. Richards, L. F. Wetherill, M. Harris, A. Kohl, R. M. Elliott, and A. Macdonald. 2010. Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog. 6: e1000778.
23. Rezaie, T., A. Child, R. Hitchings, G. Brice, L. Miller, M. Coca-Prados, E. Héon, T. Krupin, R. Ritch, D. Kreutzer, et al. 2002. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079.
24. Maruyama, H., H. Morino, H. Ito, Y. Izumi, H. Kato, Y. Watanabe, Y. Kinoshita, M. Kamada, H. Nodera, H. Suzuki, et al. 2010. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226.
25. Millecamps, S., S. Boillee, E. Chabrol, W. Camu, C. Cazeneuve, F. Salachas, P. F. Pradat, V. Danel-Brunaud, N. Vandenberghe, P. Corcia, et al. 2011. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol Aging. 32: 557.e11-557.e13.
26. Belzil, V. V., H. Daoud, A. Desjarlais, J. P. Bouchard, N. Dupre, W. Camu, P. A. Dion, and G. A. Rouleau. 2011. Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis. Neurobiol Aging. 32: 555.e13-555.e14.
27. Weishaupt, J. H., S. Waibel, A. Birve, A. E. Volk, B. Mayer, T. Meyer, A. C. Ludolph, and P. M. Andersen. 2013. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol. Aging. 34: e9-e15.
28. Tumer, Z., B. Bertelsen, O. Gredal, M. Magyari, K. C. Nielsen, Lucamp, K. Gronskov, and K. Brondum-Nielsen. 2012. Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol Aging. 33: 208.e1-208.e5.
29. van Blitterswijk, M., P. W. van Vught, M. A. van Es, H. J. Schelhaas, A. J. van der Kooi, M. de Visser, J. H. Veldink, and L. H. van den Berg. 2012. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 33: 1016.e1-1016.e7.
30. Lobsiger, C. S., and D. W. Cleveland. 2007. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10: 1355-1360.
31. Lasiene, J., and K. Yamanaka. 2011. Glial cells in amyotrophic lateral sclerosis. Neurol. Res. Int. 2011: 718987.
32. Liu, P., N. A. Jenkins, and N. G. Copeland. 2003. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13: 476-484.
33. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Sato, K. Ozato, and T. Fujita. 1996. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120: 160-169.
34. Abbondanzo, S. J., I. Gadi, and C. L. Stewart. 1993. Derivation of embryonic stem cell lines. Methods Enzymol. 225: 803-823.
35. Cross, J. L., K. Kott, T. Miletic, and P. Johnson. 2008. CD45 regulates TLR-induced proinflammatory cytokine and IFN-beta secretion in dendritic cells. J. Immunol. 180: 8020-8029.
36. Dutko, F. J., and M. B. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64: 1689-1698.
37. Baker, K. E., and R. Parker. 2004. Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr. Opin. Cell Biol. 16: 293-299.
38. Thermann, R., G. Neu-Yilik, A. Deters, U. Frede, K. Wehr, C. Hagemeier, M. W. Hentze, and A. E. Kulozik. 1998. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J. 17: 3484-3494.
39. Pasparakis, M., T. Luedde, and M. Schmidt-Supprian. 2006. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ. 13: 861-872.
40. Hayden, M. S., and S. Ghosh. 2011. NF-βB in immunobiology. Cell Res. 21: 223-244.
41. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
42. Sasaki, Y., E. Derudder, E. Hobeika, R. Pelanda, M. Reth, K. Rajewsky, and M. Schmidt-Supprian. 2006. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24: 729-739.
43. Wang, G., Y. Gao, L. Li, G. Jin, Z. Cai, J. I. Chao, and H. K. Lin. 2012. K63-linked ubiquitination in kinase activation and cancer. Front Oncol 2: 5.
44. Clark, K., O. Takeuchi, S. Akira, and P. Cohen. 2011. The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 108: 17093-17098.
45. Courtois, G., and T. D. Gilmore. 2006. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25: 6831-6843.
46. Baldwin, A. S. 2012. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol. Rev. 246: 327-345.
47. DiDonato, J. A., F. Mercurio, and M. Karin. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246: 379-400.
48. Tolosa, L., V. Caraballo-Miralles, G. Olmos, and J. Lladó. 2011. TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB. Mol. Cell. Neurosci. 46: 176-186.
49. Krappmann, D., E. N. Hatada, S. Tegethoff, J. Li, A. Klippel, K. Giese, P. A. Baeuerle, and C. Scheidereit. 2000. The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J. Biol. Chem. 275: 29779-29787.
50. Ito, H., M. Nakamura, O. Komure, T. Ayaki, R. Wate, H. Maruyama, Y. Nakamura, K. Fujita, S. Kaneko, Y. Okamoto, et al. 2011. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation. Acta Neuropathol. 122: 223-229.
51. Kamada, M., Y. Izumi, T. Ayaki, M. Nakamura, S. Kagawa, E. Kudo, W. Sako, H. Maruyama, Y. Nishida, H. Kawakami, et al. 2013. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathology. In press.
52. Akizuki, M., H. Yamashita, K. Uemura, H. Maruyama, H. Kawakami, H. Ito, and R. Takahashi. 2013. Optineurin suppression causes neuronal cell death via NF-κB pathway. J. Neurochem. 126: 699-704.
53. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170.
54. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284: 321-325.
55. Rudolph, D., W. C. Yeh, A. Wakeham, B. Rudolph, D. Nallainathan, J. Potter, A. J. Elia, and T. W. Mak. 2000. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14: 854-862.
56. Bonnard, M., C. Mirtsos, S. Suzuki, K. Graham, J. Huang, M. Ng, A. Itié, A. Wakeham, A. Shahinian, W. J. Henzel, et al. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19: 4976-4985.
57. Perry, A. K., E. K. Chow, J. B. Goodnough, W. C. Yeh, and G. Cheng. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J. Exp. Med. 199: 1651-1658.
58. Zhou, J., R. Wu, A. A. High, C. A. Slaughter, D. Finkelstein, J. E. Rehg, V. Redecke, and H. Häcker. 2011. A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. Proc. Natl. Acad. Sci. USA 108: E998-E1006.
59. Juriloff, D. M., and M. J. Harris. 2000. Mouse models for neural tube closure defects. Hum. Mol. Genet. 9: 993-1000.
60. Sakamaki, K., T. Inoue, M. Asano, K. Sudo, H. Kazama, J. Sakagami, S. Sakata, M. Ozaki, S. Nakamura, S. Toyokuni, et al. 2002. Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ. 9: 1196-1206.
61. McWhirter, S. M., K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101: 233-238.
62. Aichele, P., H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke, and S. Vucikuja. 2006. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176: 4525-4529.
63. tenOever, B. R., S. Sharma, W. Zou, Q. Sun, N. Grandvaux, I. Julkunen, H. Hemmi, M. Yamamoto, S. Akira, W. C. Yeh, et al. 2004. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78: 10636-10649.
64. Sahlender, D. A., R. C. Roberts, S. D. Arden, G. Spudich, M. J. Taylor, J. P. Luzio, J. Kendrick-Jones, and F. Buss. 2005. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J. Cell Biol. 169: 285-295.
65. del Toro, D., J. Alberch, F. Lázaro-Diéguez, R. Martín-Ibáñez, X. Xifró, G. Egea, and J. M. Canals. 2009. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol. Biol. Cell 20: 1478-1492.
66. Nagabhushana, A., M. L. Chalasani, N. Jain, V. Radha, N. Rangaraj, D. Balasubramanian, and G. Swarup. 2010. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol. 11: 4.
67. Wild, P., H. Farhan, D.G. McEwan, S.Wagner, V. V. Rogov, N. R. Brady, B. Richter, J. Korac, O. Waidmann, C. Choudhary, et al. 2011. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333: 228-233.
68. Tumbarello, D. A., B. J. Waxse, S. D. Arden, N. A. Bright, J. Kendrick-Jones, and F. Buss. 2012. Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat. Cell Biol. 14: 1024-1035.
69. Kachaner, D., J. Filipe, E. Laplantine, A. Bauch, K. L. Bennett, G. Superti-Furga, A. Israël, and R. Weil. 2012. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol. Cell 45: 553-566.